PTT-4256

· Pathios Therapeutics Pty Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PTT-4256, covering 2026-02-10 to 2026-02-10. Get the full timeline:

Most recent: Clinical Trial Update: An Open Label Dose Finding Study of PTT-4256 in Patients With Solid Tumours (RAISIC-1). [Phase 1, Phase 2]